This clinical trial evaluates barriers to prostate cancer screening in Black, faith-based communities and the impact of a modified prostate cancer education video incorporating the Prostate Cancer Foundation (PCF) Screening Guidelines for Black Men on prostate cancer knowledge and intention to screen. Black men are at an increased risk for prostate cancer and are in general less likely to be screened for prostate cancer. Determining how patients make decisions about screening for prostate cancer may help researchers develop prostate cancer screening education that is relevant to Black men within the church. An educational video modified to incorporate the new PCF Screening Guidelines for Black Men may be an effective method to help people learn about prostate cancer and screening guidelines. This may improve prostate cancer knowledge and increase screening in Black men in faith-based communities.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06838325.
PRIMARY OBJECTIVE:
I. To determine barriers to prostate cancer screening in Black faith-based communities through focus group assessments which will inform a culturally relevant prostate cancer education and early detection program.
SECONDARY OBJECTIVES:
I. To create a prostate cancer education program that is culturally relevant, and informed by the PCF Screening Guidelines for African American Men.
II. To determine the efficacy of a faith-based prostate cancer education program through a pilot study.
OUTLINE: Participants are assigned to 1 of 2 phases.
PHASE I: Participants participate in a focus group regarding barriers of prostate cancer screening in the Black community, provide feedback on the Listen up II: Prostate Cancer Awareness through Education educational video, and review the new PCF Screening Guidelines for Black Men over 2 hours in support of educational video refinement on study.
PHASE II: Participants review the modified prostate cancer education video on study.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationM D Anderson Cancer Center
Principal InvestigatorMatthew Terrence Smith
